Controlled ocular drug delivery with nanomicelles

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 6, Issue 5, 2014, Pages 422-437

  Vaishya, Ravi D ^a   Khurana, Varun ^a,b   Patel, Sulabh ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b INSYS Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTECTION; MOLECULES; OPHTHALMOLOGY;

AGE-RELATED MACULAR DEGENERATION; AMPHIPHILIC MOLECULES; CONFLICTS OF INTEREST; DIABETIC RETINOPATHY; DRUG DELIVERY SYSTEM; HYDROPHOBIC MOLECULES; OCULAR DRUG DELIVERY; SUPRAMOLECULAR STRUCTURE;

DRUG DELIVERY;

ANTISENSE OLIGONUCLEOTIDE; CHITOSAN; CYCLOSPORIN A; DEXAMETHASONE; ETHOXZOLAMIDE; HYDROGENATED CASTOR OIL; MACROGOL STEARATE; METIPRANOLOL; MUCIN; NANOCARRIER; NANOMATERIAL; NANOMICELLE; PILOCARPINE; POLOXAMER; RAPAMYCIN; SURFACTANT; UNCLASSIFIED DRUG; VOCLOSPORIN; DRUG CARRIER; EYE DROPS; MICELLE;

AQUEOUS SOLUTION; ARTICLE; CASE STUDY; CELL SURFACE; CRITICAL MICELLE CONCENTRATION; DELAYED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG UPTAKE; ENCAPSULATION; ENDOCYTOSIS; EYE DISEASE; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; INTRAOCULAR PRESSURE; MACROMOLECULE; MICELLIZATION; MOLECULAR WEIGHT; NONHUMAN; OSMOLARITY; PARTICLE SIZE; PATIENT COMPLIANCE; POLYMERIZATION; PRIORITY JOURNAL; RIGIDITY; STATIC ELECTRICITY; SURFACE CHARGE; VITREOUS BODY; ANIMAL; CHEMICAL PHENOMENA; MICELLE; RABBIT;

ANIMALS; DRUG CARRIERS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; NANOSTRUCTURES; OPHTHALMIC SOLUTIONS; RABBITS;

EID: 84905001982     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1272     Document Type: Article

References (65)

1. Ananthula HK, Vaishya RD, Barot M, Mitra AK. Bioavailability. New York, NY: Lippincott Williams & Wilkins; 2009.
2. Dursun D, Monroy D, Knighton R, Tervo T, Vesaluoma M, Carraway K, Feuer W, Pflugfelder SC. The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology 2000, 107:1754-1760.
3. Mishima S, Gasset A, Klyce SD Jr, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol 1966, 5:264-276.
4. Lens A, Langley T, Nemeth SC, Shea C. Ocular Anatomy and Physiology. Thorofare, NJ: SLACK, Incorporated; 1999.
5. Shintaro Nakao AH-M, Tatsuro I. Lymphatics and lymphangiogenesis in the eye. J Ophthalmol 2012, 2012:13-23.
6. Srirangam R, Majumdar S. Transscleral drug delivery to the posterior segment of the eye: particulate and colloidal formulations and biopharmaceutical considerations. In A.K. Mitra, ed. Advances in Ocular Drug Delivery. Kerala, India: Research Signpost; 2012.
7. Barsotti MF, Bartels SP, Freddo TF, Kamm RD. The source of protein in the aqueous humor of the normal monkey eye. Invest Ophthalmol Vis Sci 1992, 33:581-595.
8. Schlingemann RO, Hofman P, Klooster J, Blaauwgeers HG, Van der Gaag R, Vrensen GF. Ciliary muscle capillaries have blood-tissue barrier characteristics. Exp Eye Res 1998, 66:747-754.
9. Anand B, Nashed Y, Mitra A. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: bioreversion, antiviral activity and transport across rabbit cornea. Curr Eye Res 2003, 26:151-163.
10. Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm 2005, 60:207-225.
11. Stewart PA, Tuor UI. Blood-eye barriers in the rat: correlation of ultrastructure with function. J Comp Neurol 1994, 340:566-576.
12. Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol 1997, 93:149-157.
13. Pepić I, Jalšenjak N, Jalšenjak I. Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm 2004, 272:57-64.
14. Ribeiro A, Sandez-Macho I, Casas M, Alvarez-Perez S, Alvarez-Lorenzo C, Concheiro A. Poloxamine micellar solubilization of alpha-tocopherol for topical ocular treatment. Colloids Surf B Biointerfaces 2013, 103:550-557.
15. Ribeiro A, Sosnik A, Chiappetta DA, Veiga F, Concheiro A, Alvarez-Lorenzo C. Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy. J R Soc Interface 2012, 9:2059-2069.
16. Di Tommaso C, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Moller M. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm 2011, 416:515-524.
17. Di Tommaso C, Como C, Gurny R, Moller M. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations. Eur J Pharm Sci 2010, 40:38-47.
18. Di Tommaso C, Bourges JL, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny JC, Behar-Cohen F, Gurny R, Moller M. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur J Pharm Biopharm 2012, 81:257-264.
19. Di Tommaso C, Valamanesh F, Miller F, Furrer P, Rodriguez-Aller M, Behar-Cohen F, Gurny R, Moller M. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Invest Ophthalmol Vis Sci 2012, 53:2292-2299.
20. Tu J, Pang H, Yan Z, Li P. Ocular permeability of pirenzepine hydrochloride enhanced by methoxy poly(ethylene glycol)-poly(D, L-lactide) block copolymer. Drug Dev Ind Pharm 2007, 33:1142-1150.
21. Pepić I, Hafner A, Lovrić J, Pirkić B, Filipović-Grčić J. A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation. J Pharm Sci 2010, 99:4317-4325.
22. Lin HR, Chang PC. Novel pluronic-chitosan micelle as an ocular delivery system. J Biomed Mater Res B Appl Biomater 2013, 101:689-699.
23. Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, Davaran S. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res 2010, 35:1081-1089.
24. Vaishya R, Gokulgandhi M, Patel S, Minocha M, Mitra AK. Novel Dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis. AAPS. PharmSciTech 2014.
25. Gupta AK, Madan S, Majumdar DK, Maitra A. Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm 2000, 209:1-14.
26. Qu X, Khutoryanskiy VV, Stewart A, Rahman S, Papahadjopoulos-Sternberg B, Dufes C, McCarthy D, Wilson CG, Lyons R, Carter KC, et al. Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude. Biomacromolecules 2006, 7:3452-3459.
27. Kim H, Choi JS, Kim KS, Yang JA, Joo CK, Hahn SK. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization. Acta Biomater 2012, 8:3932-3940.
28. Liaw J, Chang SF, Hsiao FC. In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles. Gene Ther 2001, 8:999-1004.
29. Kuwano M, Ibuki H, Morikawa N, Ota A, Kawashima Y. Cyclosporine A formulation affects its ocular distribution in rabbits. Pharm Res 2002, 19:108-111.
30. Luschmann C, Herrmann W, Strauss O, Luschmann K, Goepferich A. Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation. Int J Pharm 2013, 455:331-337.
31. Civiale C, Licciardi M, Cavallaro G, Giammona G, Mazzone MG. Polyhydroxyethylaspartamide-based micelles for ocular drug delivery. Int J Pharm 2009, 378:177-186.
32. Luschmann C, Tessmar J, Schoeberl S, Strau O, Luschmann K, Goepferich A. Self-assembling colloidal system for the ocular administration of cyclosporine a. Cornea 2014, 33:77-81.
33. Pepic I, Lovric J, Filipovic-Grcic J. Polymeric micelles in ocular drug delivery: rationale, Strategies and Challenges. Chem Biochem Eng Q 2012, 26:365.
34. Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opin Drug Deliv 2006, 3:139-162.
35. Chi SC, Yeom DI, Kim SC, Park ES. A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate. Arch Pharm Res 2003, 26:173-181.
36. Gong C, Wei X, Wang X, Wang Y, Guo G, Mao Y, Luo F, Qian Z. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 2010, 21:215103.
37. Kim S, Park K. 19 Polymer micelles for drug delivery. 2010.
38. Chien Y. Novel Drug Delivery Systems. Marcel Dekker Inc; 1982.
39. Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 2005, 57:1555-1563.
40. Pepic I, Jalsenjak N, Jalsenjak I. Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm 2004, 272:57-64.
41. Lin H-R, Chang P-C. Novel pluronic-chitosan micelle as an ocular delivery system. J Biomed Mater Res B Appl Biomater 2013, 101B:689-699.
42. Di Tommaso C, Como C, Gurny R, Möller M. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations. Eur J Pharm Sci 2010, 40:38-47.
43. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996, 80:S40-S45.
44. El Tayar N, Mark AE, Vallat P, Brunne RM, Testa B, van Gunsteren WF. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. J Med Chem 1993, 36:3757-3764.
45. Di Tommaso C, Bourges J-L, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny J-C, Behar-Cohen F, Gurny R, Möller M. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur J Pharm Biopharm 2012, 81:257-264.
46. Di Tommaso C, Valamanesh F, Miller F, Furrer P, Rodriguez-Aller M, Behar-Cohen F, Gurny R, Möller M. A novel cyclosporin A aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Invest Ophthalmol Vis Sci 2012, 53:2292-2299.
47. Xu L, Xu X, Chen H, Li X. Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye. Colloids Surf B Biointerfaces 2013, 112:30-34.
48. Di Tommaso C, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Möller M. Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm 2011, 416:515-524.
49. Vadlapudi AD, Cholkar K, Vadlapatla RK, Mitra AK. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. J Ocul Pharmacol Ther 2013.
50. Mitra AK, Velagaleti PR, Natesan S. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors. 2011. Available at: http://www.google.com.mx/patents/US20110300195.
51. Velagaleti PRAE, Khan IJ, Gilger BC, Mitra AK. Topical delivery of hydrophobic drugs using a novel mixed nanomicellar technology to treat diseases of the anterior and posterior segments of the eye. Drug Delivery Today 2010, 10:42-47.
52. Chopra P, Hao J, Li SK. Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera. J Control Release 2012, 160:96-104.
53. Harada A, Kataoka K. Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium. Macromolecules 1998, 31:288-294.
54. Zhang GD, Harada A, Nishiyama N, Jiang DL, Koyama H, Aida T, Kataoka K. Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer. J Control Release 2003, 93:141-150.
55. Itaka K, Yamauchi K, Harada A, Nakamura K, Kawaguchi H, Kataoka K. Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer as serum-tolerable polyplex system: physicochemical properties of micelles relevant to gene transfection efficiency. Biomaterials 2003, 24:4495-4506.
56. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003, 92:1343-1355.
57. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47:113-131.
58. Katayose S, Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug Chem 1997, 8:702-707.
59. Castro E, Taboada P, Mosquera V. Behavior of a styrene oxide-ethylene oxide diblock copolymer/surfactant system: a thermodynamic and spectroscopy study. J Phys Chem B 2005, 109:5592-5599.
60. Harada A, Kataoka K. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules 1995, 28:5294-5299.
61. Kataoka K, Togawa H, Harada A, Yasugi K, Matsumoto T, Katayose S. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 1996, 29:8556-8557.
62. Kabanov AV, Vinogradov SV, Suzdaltseva YG, Alakhov V. Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconjug Chem 1995, 6:639-643.
63. Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K. Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats. FEBS Lett 2004, 557:21-25.
64. Sugisaki K, Usui T, Nishiyama N, Jang WD, Yanagi Y, Yamagami S, Amano S, Kataoka K. Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins. Invest Ophthalmol Vis Sci 2008, 49:894-899.
65. Harada A, Kataoka K, Tamaki Y, Tasaka F. Ophthalmic drug delivery system using polymer micell. 2005. Available at: http://www.google.com/patents/EP1609465A1?cl=en.